Sun Jian David Sells Shares of 111, Inc. (YI)

Sun Jian David recently sold 29,280 shares of 111, Inc., a healthcare company trading on NasdaqGM under the ticker YI. The sale took place on May 26, 2026, for a total value of $7,905.60, at an average price of $0.27 per share. This was not part of a pre-planned trading program.

Other Institutional Activity in 111, Inc.

Several institutional investors have adjusted their positions in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, bringing its total to 13,014 shares worth approximately $84,851. Serenus Wealth Advisors, LLC slightly reduced its position by 64 shares, now holding 4,320 shares valued at $321,334. Citigroup Inc added 207 shares, ending with a total of 207 shares valued at $1,341. Meanwhile, SBI Securities Co., Ltd. maintained its position with 144 shares valued at $939, and Morgan Stanley cut its holdings by 27 shares, now holding 113 shares worth $737.

111, Inc. Stock Snapshot

Shares of NasdaqGM:YI recently traded around $4.57. 111, Inc. has a market capitalization of about $40.2 million and a forward P/E ratio of 32.64. The stock has shown a 52-week range between $2.48 and $11.17. It has a 50-day moving average of $5.88 and a 200-day moving average of $5.40. The company's current ratio is 1.084, with a quick ratio of 0.366 and a debt-to-equity ratio of 150.925.

Recent Earnings

111, Inc. reported revenue of approximately $11.39 billion, although it experienced a revenue decline of 33.1%. The company posted a net margin of -0.753% and a return on equity of -14.842%. The next earnings report is expected on March 19, 2026.

Insider Buying and Selling at 111, Inc.

In addition to Sun Jian David's recent sale, several other insider transactions have occurred. On June 15, 2026, Sun Jian David sold 58,800 shares at $0.23 each, and Chen Yang Luke sold 44,000 shares at the same price. Earlier, on June 12, 2026, Chen Yang Luke sold 49,920 shares. Sun Jian David had also sold 111,100 shares on June 11, and 115,440 shares on June 10, at prices of $0.22 and $0.23 per share, respectively.

About 111, Inc.

111, Inc. operates an integrated online and offline platform in China's healthcare market. It offers B2C and B2B services, including supply chain integration, product promotion, and customer analytics. The company runs an online wholesale pharmacy and a retail pharmacy marketplace that sells various health and wellness products. Headquartered in Shanghai, 111, Inc. was founded in 2010 and is led by CEO Mr. Junling Liu.

Bottom Line

Sun Jian David's recent sale of shares in 111, Inc. is part of ongoing insider activity at the company. Investors keep an eye on these transactions as they can provide insights into insider sentiment. However, it's important to remember that these filings are backward-looking and may not reflect current positions. 111, Inc. continues to operate in the healthcare sector with a focus on leveraging both online and offline channels.